Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Wesley Clark | M | 78 | 3 years | |
| John Brennan | M | 67 | 3 years | |
| Linda Maxwell | M | 50 | 3 years | |
| Regan Lauer | F | 55 | 3 years | |
| Helen Luu | F | - | 3 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Giovanni Caforio | M | 59 | 24 years | |
| Charles A. Heimbold | M | - | 20 years | |
| Thomas Wiggans | M | 72 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 8 years |
| Kevin Starr | M | 61 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 4 years |
| Peter Radovich | M | 46 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 2 years |
| Lisa Adler | F | - |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | - |
| John Bishop | M | 62 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 4 years |
| Jason Haddock | M | 54 | 14 years | |
| Laurie Keating | F | 70 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 10 years |
| Rosemary Crane | F | 64 | 20 years | |
| Timothy Meeker | M | 77 | 13 years | |
| Barry J. Wolfenson | M | 57 | 23 years | |
| Marilyn E. Wortzman | F | 77 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 9 years |
| Brian Daniels | M | 65 | 14 years | |
| John E. Elicker | M | 64 | 20 years | |
| Joseph Squicciarino | M | 67 | 22 years | |
| Erik Harris | M | 54 | 2 years | |
| Patricia Bellinger | F | 63 | 5 years | |
| John Crowley | M | 57 | 2 years | |
| Charles M. Urbain | M | 70 | 14 years | |
| James E. Foley | M | - | - | |
| Enrique Sendagorta Gomendio | M | - | - | |
| Beth Anne Piper | M | - | 4 years | |
| Robert Peach | M | 68 | 9 years | |
| Rebecca Taub | M | 71 | 3 years | |
| Todd Yancey | M | - |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
| William Sharbaugh | M | 61 | 6 years | |
| Roger Theodoredis | M | 65 | 3 years | |
| Emma Reeve | F | 63 | 8 years | |
| Corinne Nevinny | F | 64 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 8 years |
| Wenqing Yao | M | 61 | 6 years | |
| Paul Herbert Chew | M | 72 | 9 years | |
| Arturo O. Araya | M | 53 | 3 years | |
| Laura Bessen | M | 61 | 15 years | |
| Chris Keller | M | - | 3 years | |
| Andrew Combs | M | 58 | 1 years | |
| David Cohen | M | - | 8 years | |
| Anup Marda | M | 46 | 18 years | |
| Adam Dubow | M | 57 | - | |
| Kimberly Gentile | F | 56 | 14 years | |
| Charles Conway | M | 62 | 17 years | |
| Amit Rakhit | M | 54 | 10 years | |
| Fu-Min Su | M | - | 6 years | |
| Elizabeth Yamashita | F | - | 6 years | |
| Dieter Weinand | M | 63 | 9 years | |
| Stephen McAndrew | M | - | 8 years | |
| Antoine Grouès | M | - | - | |
| Michael Giordano | M | 66 | 18 years | |
| Susan Holmes | F | - | 3 years | |
| Ning Yan | M | - | 7 years | |
| Thomas J. McKearn | M | 75 | 10 years | |
| Sonja Nelson | F | 51 | - | |
| Peter Kiener | M | 72 | 18 years | |
| Jane A. Kramer | F | 68 | 11 years | |
| John F. Bedard | M | 74 | - | |
| Michael A. Popson | M | - | 6 years | |
| Bruce Wendel | M | 70 | 14 years | |
| Faheem Hasnain | M | 65 | 2 years | |
| Jun Bao | M | 58 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | - |
| David K. Bol | M | 58 | 6 years | |
| Barry A. Labinger | M | 60 | 3 years | |
| David L. Zabor | M | 69 | - | |
| James G. Ham | M | 74 | 7 years | |
| Lynn H. Clark | F | 66 | 8 years | |
| Scott M. Freeman | M | 67 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 5 years |
| Dean Mitchell | M | 68 | 3 years | |
| Wendy Dixon | M | 68 | 8 years | |
| Stephen E. Bear | M | 73 | 7 years | |
| Steven E. Benner | M | 64 | 7 years | |
| Ronald A. Pepin | M | 68 | 10 years | |
| Timothy P. Cost | M | 65 | 5 years | |
| William P. Keane | M | 68 | 1 years | |
| Andrew Shenker | M | 69 | 5 years | |
| Susan Mahony | M | 59 | 5 years | |
| David E. Martin | M | 57 | 2 years | |
| Robert L. Simon | M | 79 | 13 years | |
| Gary Dickinson | M | 72 | 4 years | |
| Michael J. Howerton | M | 72 | - | |
| David Apelian | M | 59 | 2 years | |
| Rick Winningham | M | 64 | 4 years | |
| Andrew Bodnar | M | 75 | - | |
| Stacey Latuche | F | - | - | |
| Jaisim Shah | M | 63 | 3 years | |
| Andrew Bonfield | M | 61 | 5 years | |
| Henry Fuchs | M | 66 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 3 years |
| Helen Torley | M | 61 | 5 years | |
| Tamar Howson | F | 75 | 6 years | |
| Myrtle Potter | F | 65 | 4 years | |
| Gregory W. Schafer | M | 59 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 3 years |
| George Scangos | M | 76 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | 5 years |
| Kenneth E. Weg | M | 85 | 10 years | |
| Michael Mee | M | 81 | 7 years | |
| Stephen Sadove | M | 72 | 10 years | |
| Christine Poon | F | 71 | 3 years | |
| debra j bass | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Fabio M. Benedetti
- Personal Network
